Artykuły w czasopismach na temat „Accomodation support”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Accomodation support”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Russo, Alexandra, Francesca Alt, Marie Astrid Neu, Stefan Eder, Arthur Wingerter, Khalifa El Malki, Bernhard Lammle i Joerg Faber. "Hemophagocytic Lymphohistiocytosis in Early Infancy- Pitfall of Differentiation between Hereditary and Infectious Reasons". Blood 132, Supplement 1 (29.11.2018): 4961. http://dx.doi.org/10.1182/blood-2018-99-117519.
Pełny tekst źródłaBarco, Stefano, Stefanie Sollfrank, Alice Trinchero, Luigi Tomao, Barbara Zieger, Johanna A. Kremer Hovinga, Laura Conti i in. "Detection and Differential Diagnosis of Prekallikrein Deficiency: Genetic Study of New Families and Systematic Review of the Literature". Blood 132, Supplement 1 (29.11.2018): 2496. http://dx.doi.org/10.1182/blood-2018-99-116030.
Pełny tekst źródłaGorodianska, L., i L. Tsiukalo. "THE SOURCES FOR FINANCING THE ACCOMODATION SUPPORT IN THE ARMED FORCES OF UKRAINE". Visnyk Taras Shevchenko National University of Kyiv. Military-Special Sciences, nr 3 (47) (2021): 31–37. http://dx.doi.org/10.17721/1728-2217.2021.47.31-37.
Pełny tekst źródłaKomorowska, Olga. "Funkcjonowanie dorosłych osób z niepełnosprawnością w Niemczech". Ekonomia 23, nr 1 (15.03.2017): 11–21. http://dx.doi.org/10.19195/2084-4093.23.1.2.
Pełny tekst źródłaRiyanto, Sugeng. "KERANGKA PENGEMBANGAN SITUS CANDI LOSARI: Kajian Awal untuk Pengembangan Penelitian, Pendidikan, dan Kepariwisataan". Berkala Arkeologi 28, nr 1 (28.05.2008): 46–56. http://dx.doi.org/10.30883/jba.v28i1.354.
Pełny tekst źródłaSzenes, Eva, Andrea Härzschel, Erika Tissino, Pischeli Justine, Julia Gutjahr, Sandra Pennisi, Jan Höpner i in. "BCR-Induced VLA-4 Activation in the TCL1 Transgenic Mouse Model for Chronic Lymphocytic Leukemia". Blood 134, Supplement_1 (13.11.2019): 1730. http://dx.doi.org/10.1182/blood-2019-125634.
Pełny tekst źródłaPleyer, Lisa, Michael Pfeilstocker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattersberger i in. "Expanding on Current Definitions of Hematologic Improvement in MDS, CMML and AML: Landmark Analyses of 1301 Patients Treated with Azacitidine in the Austrian Registry of Hypomethylating Agents By the AGMT-Study Group". Blood 134, Supplement_1 (13.11.2019): 3821. http://dx.doi.org/10.1182/blood-2019-128153.
Pełny tekst źródłaSimon, Florian, Adam Giza, Sandra Robrecht, Anna-Maria Fink, Paula Cramer, Julia Von Tresckow, Moritz Fürstenau i in. "Pooled Analysis of First-Line Treatment with Targeted Agents in Patients with Chronic Lymphocytic Leukemia (CLL) Aged 80 Years and Older". Blood 138, Supplement 1 (5.11.2021): 1552. http://dx.doi.org/10.1182/blood-2021-150698.
Pełny tekst źródłaBröckelmann, Paul J., Annette Plütschow, Richard Greil, Josée M. Zijlstra, Timothy Illidge, Alexander Fosså, Julia Meissner i in. "Abscopal Effect of Radiotherapy and Nivolumab in Relapsed or Refractory Hodgkin Lymphoma (AERN): An International Multicenter Single-Arm Two-Stage Phase II GHSG Trial". Blood 134, Supplement_1 (13.11.2019): 1547. http://dx.doi.org/10.1182/blood-2019-124351.
Pełny tekst źródłaRiyanti, Anti, i Andhika Chandra Lesmana. "Pengembangan Daya Tarik Wisata di Kaliurang, Yogyakarta". Journal of Indonesian Tourism, Hospitality and Recreation 5, nr 1 (1.04.2022): 115–26. http://dx.doi.org/10.17509/jithor.v5i1.45008.
Pełny tekst źródłaFürstenau, Moritz, Anke Schilhabel, Sandra Robrecht, Can Zhang, Julia Von Tresckow, Carsten Utoft Niemann, Arnon P. Kater i in. "High Resolution Assessment of Minimal Residual Disease (MRD) By Next-Generation Sequencing (NGS) and High-Sensitivity Flow Cytometry (hsFCM) in the Phase 3 GAIA (CLL13) Trial". Blood 138, Supplement 1 (5.11.2021): 72. http://dx.doi.org/10.1182/blood-2021-147729.
Pełny tekst źródłaAbdullah, Taufik, i Kiki Pebriyanti. "PENGARUH PROGRAM GREEN HOTEL TERHADAP KEPUTUSAN MENGINAP TAMU DI THE ROYALE KRAKATAU HOTEL CILEGON BANTEN". Journal : Tourism and Hospitality Essentials Journal 6, nr 1 (7.04.2016): 1023. http://dx.doi.org/10.17509/thej.v6i1.2013.
Pełny tekst źródłaFürstenau, Moritz, Sandra Robrecht, Can Zhang, Julia Von Tresckow, Carsten Utoft Niemann, Arnon P. Kater, Michael Gregor i in. "Comparison of Tumor Lysis Syndrome (TLS) Risk Reduction and Incidence in Different Venetoclax-Based Combinations within the Randomized Phase 3 GAIA (CLL13) Trial". Blood 138, Supplement 1 (5.11.2021): 2639. http://dx.doi.org/10.1182/blood-2021-147790.
Pełny tekst źródłaRummel, Mathias J., Christian Lerchenmüller, Manfred Hensel, Martin Goerner, Christian Buske, Holger Schulz, Burkhard Schmidt i in. "Two Years Rituximab Maintenance Vs. Observation after First Line Treatment with Bendamustine Plus Rituximab (B-R) in Patients with Waldenström's Macroglobulinemia (MW): Results of a Prospective, Randomized, Multicenter Phase 3 Study (the StiL NHL7-2008 MAINTAIN trial)". Blood 134, Supplement_1 (13.11.2019): 343. http://dx.doi.org/10.1182/blood-2019-121909.
Pełny tekst źródłaLudwig, Heinz, Siegfried Sormann, Niklas Zojer, Johannes Andel, Bernd L. Hartmann, Christoph Tinchon, Eberhard Gunsilius i in. "Carfilzomib-Revlimid-Dexamethasone Vs. Carfilzomib-Thalidomide-Dexamethasone Weekly (After 2 Twice Weekly Cycles) Followed By Carfilzomib Maintenance Vs. Control in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) - Interim Efficacy Analysis of Combined Data (AGMT MM-02)". Blood 134, Supplement_1 (13.11.2019): 696. http://dx.doi.org/10.1182/blood-2019-127954.
Pełny tekst źródłaEichhorst, Barbara, Carsten Niemann, Arnon P. Kater, Moritz Fürstenau, Julia Von Tresckow, Can Zhang, Sandra Robrecht i in. "A Randomized Phase III Study of Venetoclax-Based Time-Limited Combination Treatments (RVe, GVe, GIVe) Vs Standard Chemoimmunotherapy (CIT: FCR/BR) in Frontline Chronic Lymphocytic Leukemia (CLL) of Fit Patients: First Co-Primary Endpoint Analysis of the International Intergroup GAIA (CLL13) Trial". Blood 138, Supplement 1 (5.11.2021): 71. http://dx.doi.org/10.1182/blood-2021-146161.
Pełny tekst źródłaWidiantara, Ida Bagus Gde, i I. Wayan Suastawa. "Warm Water Pool System Simulation: Design and Manufacture". Logic : Jurnal Rancang Bangun dan Teknologi 20, nr 3 (30.11.2020): 205–9. http://dx.doi.org/10.31940/logic.v20i3.2136.
Pełny tekst źródłaBartle, John, Agustí Bosch i Lluís Orriols. "The policy mood in Spain: the thermostat in a warm climate, 1978–2017". European Political Science Review 12, nr 2 (14.02.2020): 133–53. http://dx.doi.org/10.1017/s175577392000003x.
Pełny tekst źródłaEl Hafizah, Nafilah, Ervina Ahyudanari i Valeriana Lukitosari. "Tourist Response as Water-based Seaplane Purposes for Island Tourism: A Literature Review". E3S Web of Conferences 434 (2023): 02021. http://dx.doi.org/10.1051/e3sconf/202343402021.
Pełny tekst źródłaBernard, Sophie, Hervé Ghesquieres, Rene-Olivier Casasnovas, Maria Gomes Da Silva, Pierre Feugier, Franck Morschhauser, Judith Trotman i in. "Lenalidomide As Maintenance Therapy after R-CHOP Has No Protecting Effect for Central Nervous System Relapse in Frontline Treatment of Diffuse Large B-Cells Lymphoma. an Ancillary Studies of the Remarc Study". Blood 136, Supplement 1 (5.11.2020): 22–23. http://dx.doi.org/10.1182/blood-2020-136912.
Pełny tekst źródłaAnggoro, Rena Ratri, i Mochammad Bagus Qomaruddin. "ASSOCIATIVE SOCIAL INTERACTIONS OF EX-LEPROSY PATIENTS IN SUMBERGLAGAH VILLAGE OF MOJOKERTO REGENCY". Indonesian Journal of Public Health 14, nr 1 (5.07.2019): 127. http://dx.doi.org/10.20473/ijph.v14i1.2019.130-140.
Pełny tekst źródłaAnggoro, Rena Ratri, i Mochammad Bagus Qomaruddin. "INTERAKSI SOSIAL ASOSIATIF EKS PENDERITA KUSTA DI DUSUN SUMBERGLAGAH, KABUPATEN MOJOKERTO". Indonesian Journal of Public Health 14, nr 1 (5.07.2019): 127. http://dx.doi.org/10.20473/ijph.v14i1.2019.127-137.
Pełny tekst źródłaDharawanij, Noppadol. "The Ways to Promote Wellness Tourism in Muang District, Chachoengsao Province". International Journal of Professional Business Review 8, nr 12 (18.12.2023): e04009. http://dx.doi.org/10.26668/businessreview/2023.v8i12.4009.
Pełny tekst źródłaBrauneck, Franziska, Brit Fischer, Jasmin Wellbrock, Carsten Bokemeyer, Julian Schulze zur Wiesch, Friedrich Haag, Christin Ackermann i Walter Fiedler. "Blockade of Tigit on AML-Derived M2 Macrophages Results in Reprograming into the M1 Phenotype and Enhances CD47-Mediated Phagocytosis". Blood 138, Supplement 1 (5.11.2021): 3351. http://dx.doi.org/10.1182/blood-2021-148075.
Pełny tekst źródłaSeymour, John F., Jenny Qun Wu, Relja Popovic, Barbara Eichhorst, Peter Hillmen, Thomas J. Kipps, Anton W. Langerak i in. "Assessment of the Clonal Dynamics of Acquired Mutations in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Treated in the Randomized Phase 3 Murano Trial Supports Venetoclax-Rituximab (VenR) Fixed-Duration Combination Treatment (Tx)". Blood 138, Supplement 1 (5.11.2021): 1548. http://dx.doi.org/10.1182/blood-2021-147731.
Pełny tekst źródłaBottoni, Stefano. "Talking to the System: Imre Mikó, 1911–1977". East Central Europe 44, nr 1 (23.06.2017): 47–75. http://dx.doi.org/10.1163/18763308-04401002.
Pełny tekst źródłaClement-Filliatre, Lauriane, Lotfi Benboubker, Anne-Marie Stoppa, Philippe Rodon, Kamel Laribi, Laure Vincent, Philippe Collet i in. "Real-Life-Setting Effectiveness of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma: The Remix Study". Blood 136, Supplement 1 (5.11.2020): 25–26. http://dx.doi.org/10.1182/blood-2020-133807.
Pełny tekst źródłaKillaspy, Helen, Stefan Priebe, Michael King, Sandra Eldridge, Paul McCrone, Geoff Shepherd, Maurice Arbuthnott i in. "Supported accommodation for people with mental health problems: the QuEST research programme with feasibility RCT". Programme Grants for Applied Research 7, nr 7 (wrzesień 2019): 1–82. http://dx.doi.org/10.3310/pgfar07070.
Pełny tekst źródłaMina, Roberto, Alessandra Larocca, Maria Teresa Petrucci, Gianluca Gaidano, Stelvio Ballanti, Pellegrino Musto, Massimo Offidani i in. "Long-Term Carfilzomib for High-Risk Patients with Newly Diagnosed Multiple Myeloma: A Pooled Analysis of Two Phase 1/2 Studies". Blood 132, Supplement 1 (29.11.2018): 3240. http://dx.doi.org/10.1182/blood-2018-99-112075.
Pełny tekst źródłaBlum, Sabine, Norbert Gattermann, Filipe Martins, Kathrin Nachtkamp, Andrea Kuendgen, Guido Kobbe i Ulrich Germing. "Is the IPSS-R Useful for Patients with MDS Receiving Disease-Modifying Treatment?" Blood 128, nr 22 (2.12.2016): 5526. http://dx.doi.org/10.1182/blood.v128.22.5526.5526.
Pełny tekst źródłaBelada, David, Katerina Kopeckova, Juan Miguel Bergua Burgues, Don Stevens, Marc André, Ernesto Pérez Persona, Petra Pichler i in. "First-Mind: Primary Analysis from a Phase Ib, Open-Label, Randomized Study to Assess Safety of Tafasitamab or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma". Blood 138, Supplement 1 (5.11.2021): 3556. http://dx.doi.org/10.1182/blood-2021-148354.
Pełny tekst źródłaMacro, Magaret, Cyrille Touzeau, Clara Mariette, Salomon Manier, Sabine Brechignac, Laure Vincent, Benjamin Hebraud i in. "Ixazomib and Daratumumab without Dexamethasone (I-Dara) in Elderly Frail RRMM Patients. a Multicenter Phase 2 Study (IFM 2018-02) of the Intergroupe Francophone Du Myélome (IFM)". Blood 138, Supplement 1 (5.11.2021): 83. http://dx.doi.org/10.1182/blood-2021-148152.
Pełny tekst źródłaBringhen, Sara, Roberto Mina, Maria Teresa Petrucci, Lorenzo De Paoli, Stelvio Ballanti, Pellegrino Musto, Massimo Offidani i in. "Once Weekly Versus Twice Weekly Carfilzomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma: A Pooled Analysis of Two Phase 1/2 Studies". Blood 132, Supplement 1 (29.11.2018): 1990. http://dx.doi.org/10.1182/blood-2018-99-111252.
Pełny tekst źródłaPleyer, Lisa, Michael Leisch, Alexandra Kourakli, Eric Padron, Jaroslaw P. Maciejewski, Blanca Xicoy, Jennifer Kaivers i in. "Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study Group". Blood 134, Supplement_1 (13.11.2019): 844. http://dx.doi.org/10.1182/blood-2019-123941.
Pełny tekst źródłaZaccaria, Gian Maria, Andrea Capra, Maria Teresa Petrucci, Massimo Offidani, Vittorio Montefusco, Francesco Di Raimondo, Annalisa Bernardini i in. "Predictive Model of Early Relapse in Newly Diagnosed Multiple Myeloma: Analysis from a Pooled Dataset". Blood 134, Supplement_1 (13.11.2019): 2130. http://dx.doi.org/10.1182/blood-2019-125640.
Pełny tekst źródłaPerrot, Aurore, Valerie Lauwers-Cances, Titouan Cazaubiel, Thierry Facon, Denis Caillot, Lauriane Clement-Filliatre, Margaret Macro i in. "Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial". Blood 136, Supplement 1 (5.11.2020): 39. http://dx.doi.org/10.1182/blood-2020-134538.
Pełny tekst źródłaBoquoi, Amelie, Soraya Magdalena Banahan, Judith Strapatsas, David Lopez y Niedenhoff, Guido Kobbe, Norbert Gattermann, Ulrich Germing, Rainer Haas, Thomas Schroeder i Roland Fenk. "Therapy-Related Myeloid Neoplasms Following Treatment for Multiple Myeloma : A Single-Center Analysis". Blood 134, Supplement_1 (13.11.2019): 4261. http://dx.doi.org/10.1182/blood-2019-122598.
Pełny tekst źródłaKreissl, Stefanie, Helen Goergen, Bastian von Tresckow, Karolin Behringer, Jana Markova, Andreas Lohri, Julia Meissner i in. "Primary Progressive Disease in Hodgkin Lymphoma Patients: A Retrospective Analysis from the German Hodgkin Study Group". Blood 126, nr 23 (3.12.2015): 3941. http://dx.doi.org/10.1182/blood.v126.23.3941.3941.
Pełny tekst źródłaBeksac, Meral, Simona Iacobelli, Linda Koster, Didier Blaise, Jan J. Cornelissen, Péter Reményi, Xavier Leleu i in. "A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. a Study of the EBMT Chronic Malignancies Working Party". Blood 138, Supplement 1 (5.11.2021): 3937. http://dx.doi.org/10.1182/blood-2021-147001.
Pełny tekst źródłaPerrot, Aurore, Valérie Lauwers-Cances, Cyrille Touzeau, Olivier Decaux, Cyrille Hulin, Magaret Macro, Anne-Marie Stoppa i in. "Daratumumab Plus Ixazomib, Lenalidomide, and Dexamethasone As Extended Induction and Consolidation Followed By Lenalidomide Maintenance in Standard-Risk Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (IFM 2018-01): A Phase II Study of the Intergroupe Francophone Du Myélome (IFM)". Blood 138, Supplement 1 (5.11.2021): 464. http://dx.doi.org/10.1182/blood-2021-146040.
Pełny tekst źródłaRücker, Frank G., Mridul Agrawal, Andrea Corbacioglu, Daniela Weber, Silke Kapp-Schwoerer, Verena I. Gaidzik, Nikolaus Jahn i in. "Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1) RUNX1-RUNX1T1 Identifies Patients at High Risk of Relapse: Results of the AML Study Group (AMLSG)". Blood 134, Supplement_1 (13.11.2019): 2740. http://dx.doi.org/10.1182/blood-2019-125584.
Pełny tekst źródłaNeukirchen, Judith, Pia Arat, Charlotte Teutloff, Celina Gerrlich, David Lopez y Niedenhoff, Amelie Boquoi, Ingrida Savickaite i in. "Favourable Outcome of Elderly Patients with Multiple Myeloma Treated with Tandem Melphalan 100 High-Dose Therapy, Autologous Stem Cell Transplantation and Novel Agents - a Single Center Experience". Blood 128, nr 22 (2.12.2016): 3460. http://dx.doi.org/10.1182/blood.v128.22.3460.3460.
Pełny tekst źródłaKvasnicka, Hans Michael, Juergen Thiele, Carlos E. Bueso-Ramos, William Sun, Ahmad Naim, Smitha Svaraman, Jessy Gao i in. "Effects of Long-Term Ruxolitinib (RUX) on Bone Marrow (BM) Morphology in Patients with Myelofibrosis (MF) Enrolled in the COMFORT-I Study". Blood 128, nr 22 (2.12.2016): 1949. http://dx.doi.org/10.1182/blood.v128.22.1949.1949.
Pełny tekst źródłaThieblemont, Catherine, Loïc Chartier, Ulrich Dührsen, Umberto Vitolo, Sally F. Barrington, Laetitia Vercellino, Jan Zaucha i in. "The Combination of High Total Metabolic Tumor Volume and Poor ECOG Performance Status Defines Ultra-High Risk Diffuse Large B-Cell Lymphoma. Validation across Multiple Cohorts of Large Clinical Trials and in Real World". Blood 136, Supplement 1 (5.11.2020): 30–31. http://dx.doi.org/10.1182/blood-2020-136544.
Pełny tekst źródłaLandgren, Ola, Melissa Alsina, Noa Biran, David H. Vesole, Paul K. Wallace, Belle Fang, Gregory Arnold, Amy Kimball i David S. Siegel. "Assessment of Minimal Residual Disease in a Phase 1b Study of Once-Weekly Carfilzomib Combined with Lenalidomide and Dexamethasone in Patients with Multiple Myeloma". Blood 136, Supplement 1 (5.11.2020): 28. http://dx.doi.org/10.1182/blood-2020-133803.
Pełny tekst źródłaHrusak, Ondrej, Valerie De Haas, Ales Luks, Iveta Janotova, Ester Mejstrikova, Kirsten Bleckmann, Anja Moricke i in. "Acute Leukemia of Ambiguous Lineage: A Comprehensive Survival Analysis Enables Designing New Treatment Strategies". Blood 128, nr 22 (2.12.2016): 584. http://dx.doi.org/10.1182/blood.v128.22.584.584.
Pełny tekst źródłaMuriawan Putra, Agus, i Ida Bagus Ketut Astina. "The Development of Local Accommodation to Support Subak Jatiluwih Tourism in Tabanan Regency". Udayana Journal of Social Sciences and Humanities (UJoSSH) 1, nr 1 (28.02.2017): 1. http://dx.doi.org/10.24843/ujossh.2017.v01.i01.p01.
Pełny tekst źródłaAvet Loiseau, Herve, Pieter Sonneveld, Philippe Moreau, Fritz Offner, Vincent H. J. van der Velden, Denis Caillot, Cyrille Hulin i in. "Daratumumab (DARA) with Bortezomib, Thalidomide, and Dexamethasone (VTd) in Transplant-Eligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Minimal Residual Disease (MRD) Negativity in Cassiopeia Part 1 and Part 2". Blood 138, Supplement 1 (5.11.2021): 82. http://dx.doi.org/10.1182/blood-2021-147897.
Pełny tekst źródłaAvet-Loiseau, Herve, Romain Lannes, Aurore Perrot, Céline Mazzotti, Marion Divoux, Titouan Cazaubiel, Xavier Leleu i in. "In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present from the Diagnosis in Tiny Undetectable Subclones". Blood 138, Supplement 1 (5.11.2021): 77. http://dx.doi.org/10.1182/blood-2021-146869.
Pełny tekst źródłaThieblemont, Catherine, Maria Gomes da Silva, Olivier Casasnovas, Hervé Ghesquieres, Gandhi Laurent Damaj, Judith Trotman, Pierre Feugier i in. "Final Analysis of the International Double-Blind Randomized Phase III Study of Lenalidomide Maintenance in Elderly Patients with DLBCL in Response after R-CHOP, the Remarc Study from Lysa". Blood 136, Supplement 1 (5.11.2020): 1–2. http://dx.doi.org/10.1182/blood-2020-136511.
Pełny tekst źródła